Ciencias Económicas y Empresariales
Fakultät
Beth Israel Deaconess Medical Center
Boston, Estados UnidosPublikationen in Zusammenarbeit mit Forschern von Beth Israel Deaconess Medical Center (1)
2016
-
Anti-tumor activity of PM01183 (lurbinectedin) in BRCA1/2-associated metastatic breast cancer patients: results of a single-agent phase II trial
Annals of Oncology, Vol. 27, pp. vi68